Back
Direxion Daily S&P 500® Bull 2X ETF Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Buy
64
SPUU
Direxion Daily S&P 500® Bull 2X ETF
Last Price:
131.80
Seasonality Move:
5.15%
Sell
43
RARE
Ultragenyx Pharmaceutical
Last Price:
39.82
Seasonality Move:
-0.9%
Buy
64
Direxion Daily S&P 500® Bull 2X ETF (SPUU)
is a Buy
Is Direxion Daily S&P 500® Bull 2X ETF a Buy, Sell or Hold?
- The current Direxion Daily S&P 500® Bull 2X ETF [SPUU] share price is $131.35. The Score for SPUU is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- SPUU is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $39.39. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SPUU Stock Price Chart
What is Direxion Daily S&P 500® Bull 2X ETF's stock price today?
-
The Direxion Daily S&P 500® Bull 2X ETF share price today is $131.35
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SPUU is experiencing selling pressure, which indicates risk of future bearish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $39.39
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
SPUU Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.84 | Buy |
Relative Strength Index (14 RSI): | 66.98 | Buy |
Chaikin Money Flow: | -4632 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (123.67 - 130.53) | Buy |
Bollinger Bands (100): | (113.49 - 125.47) | Buy |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.74 | Sell |
Relative Strength Index (14 RSI): | 45.16 | Sell |
Chaikin Money Flow: | -377368 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.89 - 42.13) | Sell |
Bollinger Bands (100): | (40.93 - 48.81) | Sell |
SPUU Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 131.58 | Sell |
20-day SMA: | 127.68 | Buy |
50-day SMA: | 121.85 | Buy |
200-day SMA: | 106.54 | Buy |
8-day EMA: | 131.07 | Buy |
20-day EMA: | 128.39 | Buy |
50-day EMA: | 124.02 | Buy |
200-day EMA: | 110.19 | Buy |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.13 | Sell |
20-day SMA: | 40.38 | Sell |
50-day SMA: | 41.72 | Sell |
200-day SMA: | 42.46 | Sell |
8-day EMA: | 39.68 | Sell |
20-day EMA: | 40.43 | Sell |
50-day EMA: | 41.92 | Sell |
200-day EMA: | 43.42 | Sell |
Direxion Daily S&P 500® Bull 2X ETF Earnings Growth & SPUU Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.
Direxion Daily S&P 500® Bull 2X ETF Technical Analysis
Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |